Want to join the conversation?
$ABT said that in July, it received FDA approval for its dissolvable heart stent, AbsorbTM and TECNIS Symfony intraocular lenses for the treatment of cataracts. In 2Q16, the company announced the launch of AlinIQ, a tool to help diagnostics labs manage data through increased productivity and efficiency through hospital networks.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.